Skip to main content
Erschienen in: Surgery Today 10/2012

01.10.2012 | Original Article

Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography–computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers

verfasst von: Shuichiro Uchiyama, Yukihiro Haruyama, Takashi Asada, Masayuki Hotokezaka, Shigeki Nagamachi, Kazuo Chijiiwa

Erschienen in: Surgery Today | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the role of positron emission tomography–computed tomography (PET–CT) and multidetector-row CT (MD-CT) in detecting the primary lesion and lymph node metastasis in patients with colorectal cancers.

Methods

A collective total of 80 lesions resected from 77 patients were examined pathologically. We analyzed the significance of the standardized uptake value (SUV) and its relationship with the clinicopathologic findings of primary lesions and lymph node metastasis. The detectability of primary lesions and lymph node metastases on PET–CT images was compared with that on MD-CT images.

Results

The detectability of primary lesions was better on PET–CT images than on MD-CT images (p = 0.0023). We observed no significant differences in the SUV with respect to staging, tumor grade, lymphatic or vessel invasion, and macroscopic type; however, primary tumor size analysis revealed that tumors larger than 3 cm had a higher SUV than those smaller than 3 cm. The sensitivity of PET–CT for detecting lymph node metastasis was lower than that of MD-CT, but the specificity of PET–CT was higher than that of MD-CT.

Conclusions

The SUV of primary cancers tends to increase in proportion to tumor size. Although the value of PET–CT in detecting lymph node metastasis is limited, PET -positive lymph nodes can be considered metastatic.
Literatur
1.
Zurück zum Zitat Shin S, Jeong Y, Min J, Kim H, Chung T, Kang H. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging. 2008;33:270–7.CrossRefPubMed Shin S, Jeong Y, Min J, Kim H, Chung T, Kang H. Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging. 2008;33:270–7.CrossRefPubMed
2.
Zurück zum Zitat Furukawa H, Ikuma H, Seki A, Yokoe K, Yuen S, Aramaki T, et al. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Gut. 2006;55:1007–11.CrossRefPubMedPubMedCentral Furukawa H, Ikuma H, Seki A, Yokoe K, Yuen S, Aramaki T, et al. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer. Gut. 2006;55:1007–11.CrossRefPubMedPubMedCentral
3.
4.
Zurück zum Zitat Tomikawa M, Korenaga D, Akahoshi T, Kohshi K, Sugimachi K, Ikeda Y, et al. Trends in the treatment outcomes for advanced colorectal cancer: an analysis at a single community hospital in Japan. Surg Today. 2011;41:801–5.CrossRefPubMed Tomikawa M, Korenaga D, Akahoshi T, Kohshi K, Sugimachi K, Ikeda Y, et al. Trends in the treatment outcomes for advanced colorectal cancer: an analysis at a single community hospital in Japan. Surg Today. 2011;41:801–5.CrossRefPubMed
5.
Zurück zum Zitat Chessin D, Kiran R, Akhurst T, Guillem J. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg. 2005;201:948–56.CrossRefPubMed Chessin D, Kiran R, Akhurst T, Guillem J. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg. 2005;201:948–56.CrossRefPubMed
6.
Zurück zum Zitat Abdel-Nabi H, Doerr R, Lamonica D, Cronin V, Galantowicz P, Carbone G, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998;206:755–60.CrossRefPubMed Abdel-Nabi H, Doerr R, Lamonica D, Cronin V, Galantowicz P, Carbone G, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998;206:755–60.CrossRefPubMed
7.
Zurück zum Zitat Cohade C, Osman M, Leal J, Wahl R. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med. 2003;44:1797–803.PubMed Cohade C, Osman M, Leal J, Wahl R. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med. 2003;44:1797–803.PubMed
8.
Zurück zum Zitat Park I, Kim H, Yu C, Ryu M, Chang H, Kim J, et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol. 2006;32:941–7.CrossRefPubMed Park I, Kim H, Yu C, Ryu M, Chang H, Kim J, et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol. 2006;32:941–7.CrossRefPubMed
9.
Zurück zum Zitat Selzner M, Hany T, Wildbrett P, McCormack L, Kadry Z, Clavien P. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027–34 (discussion 35–6). Selzner M, Hany T, Wildbrett P, McCormack L, Kadry Z, Clavien P. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004;240:1027–34 (discussion 35–6).
10.
Zurück zum Zitat Llamas-Elvira J, Rodríguez-Fernández A, Gutiérrez-Sáinz J, Gomez-Rio M, Bellon-Guardia M, Ramos-Font C, et al. Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging. 2007;34:859–67.CrossRefPubMed Llamas-Elvira J, Rodríguez-Fernández A, Gutiérrez-Sáinz J, Gomez-Rio M, Bellon-Guardia M, Ramos-Font C, et al. Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging. 2007;34:859–67.CrossRefPubMed
11.
Zurück zum Zitat Davey K, Heriot A, Mackay J, Drummond E, Hogg A, Ngan S, et al. The impact of 18-fluorodeoxyglucose positron emission tomography–computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum. 2008;51:997–1003.CrossRefPubMed Davey K, Heriot A, Mackay J, Drummond E, Hogg A, Ngan S, et al. The impact of 18-fluorodeoxyglucose positron emission tomography–computed tomography on the staging and management of primary rectal cancer. Dis Colon Rectum. 2008;51:997–1003.CrossRefPubMed
12.
Zurück zum Zitat Nagata K, Ota Y, Okawa T, Endo S, Kudo S. PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer. Dis Colon Rectum. 2008;51:882–90.CrossRefPubMed Nagata K, Ota Y, Okawa T, Endo S, Kudo S. PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer. Dis Colon Rectum. 2008;51:882–90.CrossRefPubMed
13.
Zurück zum Zitat Agress HJ, Cooper B. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417–22.CrossRefPubMed Agress HJ, Cooper B. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417–22.CrossRefPubMed
14.
Zurück zum Zitat Filippone A, Ambrosini R, Fuschi M, Marinelli T, Genovesi D, Bonomo L. Preoperative T and N staging of colorectal cancer: accuracy of contrast-enhanced multi-detector row CT colonography—initial experience. Radiology. 2004;231:83–90.CrossRefPubMed Filippone A, Ambrosini R, Fuschi M, Marinelli T, Genovesi D, Bonomo L. Preoperative T and N staging of colorectal cancer: accuracy of contrast-enhanced multi-detector row CT colonography—initial experience. Radiology. 2004;231:83–90.CrossRefPubMed
15.
Zurück zum Zitat Kulinna C, Eibel R, Matzek W, Bonel H, Aust D, Strauss T, et al. Staging of rectal cancer: diagnostic potential of multiplanar reconstructions with MDCT. AJR Am J Roentgenol. 2004;183:421–7.CrossRefPubMed Kulinna C, Eibel R, Matzek W, Bonel H, Aust D, Strauss T, et al. Staging of rectal cancer: diagnostic potential of multiplanar reconstructions with MDCT. AJR Am J Roentgenol. 2004;183:421–7.CrossRefPubMed
16.
Zurück zum Zitat Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol. 2008;38:347–53.CrossRefPubMed Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol. 2008;38:347–53.CrossRefPubMed
17.
Zurück zum Zitat Svrcek M, Cosnes J, Beaugerie L, Parc R, Bennis M, Tiret E, et al. Colorectal neoplasia in Crohn’s colitis: a retrospective comparative study with ulcerative colitis. Histopathology. 2007;50:574–83.CrossRefPubMed Svrcek M, Cosnes J, Beaugerie L, Parc R, Bennis M, Tiret E, et al. Colorectal neoplasia in Crohn’s colitis: a retrospective comparative study with ulcerative colitis. Histopathology. 2007;50:574–83.CrossRefPubMed
18.
Zurück zum Zitat Green J, Timmcke A, Mitchell W, Hicks T, Gathright JJ, Ray J. Mucinous carcinoma—just another colon cancer? Dis Colon Rectum. 1993;36:49–54.CrossRefPubMed Green J, Timmcke A, Mitchell W, Hicks T, Gathright JJ, Ray J. Mucinous carcinoma—just another colon cancer? Dis Colon Rectum. 1993;36:49–54.CrossRefPubMed
19.
Zurück zum Zitat Berger K, Nicholson S, Dehdashti F, Siegel B. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174:1005–8.CrossRefPubMed Berger K, Nicholson S, Dehdashti F, Siegel B. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174:1005–8.CrossRefPubMed
Metadaten
Titel
Role of the standardized uptake value of 18-fluorodeoxyglucose positron emission tomography–computed tomography in detecting the primary tumor and lymph node metastasis in colorectal cancers
verfasst von
Shuichiro Uchiyama
Yukihiro Haruyama
Takashi Asada
Masayuki Hotokezaka
Shigeki Nagamachi
Kazuo Chijiiwa
Publikationsdatum
01.10.2012
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 10/2012
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-012-0225-6

Weitere Artikel der Ausgabe 10/2012

Surgery Today 10/2012 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Metformin rückt in den Hintergrund

24.04.2024 DGIM 2024 Kongressbericht

Es hat sich über Jahrzehnte klinisch bewährt. Doch wo harte Endpunkte zählen, ist Metformin als alleinige Erstlinientherapie nicht mehr zeitgemäß.

Myokarditis nach Infekt – Richtig schwierig wird es bei Profisportlern

24.04.2024 DGIM 2024 Kongressbericht

Unerkannte Herzmuskelentzündungen infolge einer Virusinfektion führen immer wieder dazu, dass junge, gesunde Menschen plötzlich beim Sport einen Herzstillstand bekommen. Gerade milde Herzbeteiligungen sind oft schwer zu diagnostizieren – speziell bei Leistungssportlern. 

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.